{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:37:59Z","timestamp":1793162279914,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This study was supported by funding from Kerman Neuroscience Research Center","award":["03-66"],"award-info":[{"award-number":["03-66"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s13760-026-03150-5","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:36:43Z","timestamp":1785767803000},"page":"1735-1744","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dysregulation of ferroptosis-related plasma biomarkers in treatment-free patients with relapsing-remitting multiple sclerosis in clinical remission: a case-control study"],"prefix":"10.1007","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0159-5504","authenticated-orcid":false,"given":"Mahdieh","family":"Nazari-Robati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8758-6686","authenticated-orcid":false,"given":"Beydolah","family":"Shahouzehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4108-8104","authenticated-orcid":false,"given":"Mahdis Rahimi","family":"Naiini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"issue":"5","key":"3150_CR1","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1177\/1352458519898332","volume":"26","author":"NA Patsopoulos","year":"2020","unstructured":"Patsopoulos NA, De Jager PL (2020) Genetic and gene expression signatures in multiple sclerosis. Mult Scler 26(5):576\u2013581","journal-title":"Mult Scler"},{"issue":"1","key":"3150_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00281-021-00907-3","volume":"44","author":"W Kim","year":"2022","unstructured":"Kim W, Patsopoulos NA (2022) Genetics and functional genomics of multiple sclerosis. Semin Immunopathol 44(1):63\u201379","journal-title":"Semin Immunopathol"},{"issue":"1","key":"3150_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s44197-025-00353-6","volume":"15","author":"G Khan","year":"2025","unstructured":"Khan G, Hashim MJ (2025) Epidemiology of multiple sclerosis: global, regional, National and sub-national-level estimates and future projections. J Epidemiol global health 15(1):21","journal-title":"J Epidemiol global health"},{"key":"3150_CR4","doi-asserted-by":"publisher","first-page":"1591417","DOI":"10.3389\/fnins.2025.1591417","volume":"19","author":"C Xie","year":"2025","unstructured":"Xie C, Wu N, Guo J, Ma L, Zhang C (2025) The key role of the ferroptosis mechanism in neurological diseases and prospects for targeted therapy. Front NeuroSci 19:1591417","journal-title":"Front NeuroSci"},{"issue":"1","key":"3150_CR5","doi-asserted-by":"publisher","first-page":"9074206","DOI":"10.1155\/2021\/9074206","volume":"2021","author":"A Sharma","year":"2021","unstructured":"Sharma A, Flora SJS (2021) Positive and negative regulation of ferroptosis and its role in maintaining metabolic and redox homeostasis. Oxidative Med Cell Longev 2021(1):9074206","journal-title":"Oxidative Med Cell Longev"},{"issue":"5","key":"3150_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/10738584221100183","volume":"29","author":"S David","year":"2023","unstructured":"David S, Ryan F, Jhelum P, Kroner A (2023) Ferroptosis in neurological disease. Neuroscientist 29(5):591\u2013615","journal-title":"Neuroscientist"},{"issue":"1","key":"3150_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156(1):317\u2013331","journal-title":"Cell"},{"issue":"9","key":"3150_CR8","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D (2021) Ferroptosis: machinery and regulation. Autophagy 17(9):2054\u20132081","journal-title":"Autophagy"},{"issue":"3","key":"3150_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s12017-023-08744-3","volume":"25","author":"M Mohammadinasr","year":"2023","unstructured":"Mohammadinasr M, Montazersaheb S, Molavi O, Kahroba H, Talebi M, Ayromlou H et al (2023) Multiplex analysis of cerebrospinal fluid and serum exosomes MicroRNAs of untreated relapsing remitting multiple sclerosis (RRMS) and proposing noninvasive diagnostic biomarkers. Neuromol Med 25(3):402\u2013414","journal-title":"Neuromol Med"},{"issue":"8","key":"3150_CR10","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41423-022-00883-0","volume":"19","author":"J Luoqian","year":"2022","unstructured":"Luoqian J, Yang W, Ding X, Tuo Q-z, Xiang Z, Zheng Z et al (2022) Ferroptosis promotes T-cell activation-induced neurodegeneration in multiple sclerosis. Cell Mol Immunol 19(8):913\u2013924","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"3150_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrn3820","volume":"15","author":"RP Bazinet","year":"2014","unstructured":"Bazinet RP, Lay\u00e9 S (2014) Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci 15(12):771\u2013785","journal-title":"Nat Rev Neurosci"},{"key":"3150_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3389\/fnins.2020.00823","volume":"14","author":"S-Y Zhang","year":"2020","unstructured":"Zhang S-Y, Gui L-N, Liu Y-Y, Shi S, Cheng Y (2020) Oxidative stress marker aberrations in multiple sclerosis: a meta-analysis study. Front NeuroSci 14:823","journal-title":"Front NeuroSci"},{"key":"3150_CR13","doi-asserted-by":"publisher","first-page":"102941","DOI":"10.1016\/j.msard.2021.102941","volume":"51","author":"NA Ghonimi","year":"2021","unstructured":"Ghonimi NA, Elsharkawi KA, Khyal DS, Abdelghani AA (2021) Serum malondialdehyde as a lipid peroxidation marker in multiple sclerosis patients and its relation to disease characteristics. Multiple Scler Relat disorders 51:102941","journal-title":"Multiple Scler Relat disorders"},{"issue":"8","key":"3150_CR14","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1007\/s10072-020-04928-y","volume":"42","author":"D Obradovic","year":"2021","unstructured":"Obradovic D, Andjelic T, Ninkovic M, Dejanovic B, Kotur-Stevuljevic J (2021) Superoxide dismutase (SOD), advanced oxidation protein products (AOPP), and disease-modifying treatment are related to better relapse recovery after corticosteroid treatment in multiple sclerosis. Neurol Sci 42(8):3241\u20133247","journal-title":"Neurol Sci"},{"issue":"7","key":"3150_CR15","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1007\/s12035-018-1403-3","volume":"56","author":"A Weiland","year":"2019","unstructured":"Weiland A, Wang Y, Wu W, Lan X, Han X, Li Q et al (2019) Ferroptosis and its role in diverse brain diseases. Mol Neurobiol 56(7):4880\u20134893","journal-title":"Mol Neurobiol"},{"key":"3150_CR16","doi-asserted-by":"publisher","first-page":"598601","DOI":"10.3389\/fimmu.2021.598601","volume":"12","author":"X Xu","year":"2021","unstructured":"Xu X, Lin D, Tu S, Gao S, Shao A, Sheng J (2021) Is ferroptosis a future direction in exploring cryptococcal meningitis? Front Immunol 12:598601","journal-title":"Front Immunol"},{"key":"3150_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.brainresbull.2017.11.018","volume":"137","author":"FJ Medina-Fernandez","year":"2018","unstructured":"Medina-Fernandez FJ, Escribano BM, Luque E, Caballero-Villarraso J, Gomez-Chaparro JL, Feijoo M et al (2018) Comparative of transcranial magnetic stimulation and other treatments in experimental autoimmune encephalomyelitis. Brain Res Bull 137:140\u2013145","journal-title":"Brain Res Bull"},{"key":"3150_CR18","doi-asserted-by":"publisher","first-page":"632749","DOI":"10.3389\/fneur.2021.632749","volume":"12","author":"A Dal-Bianco","year":"2021","unstructured":"Dal-Bianco A, Schranzer R, Grabner G, Lanzinger M, Kolbrink S, Pusswald G et al (2021) Iron rims in patients with multiple sclerosis as neurodegenerative marker? A 7-Tesla magnetic resonance study. Front Neurol 12:632749","journal-title":"Front Neurol"},{"issue":"4\u20135","key":"3150_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1177\/13524585231155639","volume":"29","author":"M Wittayer","year":"2023","unstructured":"Wittayer M, Weber CE, Kittel M, Platten M, Schirmer L, Tumani H et al (2023) Cerebrospinal fluid\u2013related tissue damage in multiple sclerosis patients with iron rim lesions. Multiple Scler J 29(4\u20135):549\u2013558","journal-title":"Multiple Scler J"},{"issue":"1","key":"3150_CR20","doi-asserted-by":"publisher","first-page":"19630","DOI":"10.1038\/s41598-022-24152-2","volume":"12","author":"A Rayatpour","year":"2022","unstructured":"Rayatpour A, Foolad F, Heibatollahi M, Khajeh K, Javan M (2022) Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve. Sci Rep 12(1):19630","journal-title":"Sci Rep"},{"issue":"1","key":"3150_CR21","doi-asserted-by":"publisher","first-page":"11664","DOI":"10.1038\/s41598-019-48087-3","volume":"9","author":"RS Khan","year":"2019","unstructured":"Khan RS, Baumann B, Dine K, Song Y, Dunaief JL, Kim SF et al (2019) Dexras1 deletion and iron chelation promote neuroprotection in experimental optic neuritis. Sci Rep 9(1):11664","journal-title":"Sci Rep"},{"issue":"4","key":"3150_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s12264-020-00620-5","volume":"37","author":"Y Cao","year":"2021","unstructured":"Cao Y, Li Y, He C, Yan F, Li J-R, Xu H-Z et al (2021) Selective ferroptosis inhibitor liproxstatin-1 attenuates neurological deficits and neuroinflammation after subarachnoid hemorrhage. Neurosci Bull 37(4):535\u2013549","journal-title":"Neurosci Bull"},{"key":"3150_CR23","doi-asserted-by":"publisher","first-page":"849854","DOI":"10.3389\/fcell.2022.849854","volume":"10","author":"Y Pang","year":"2022","unstructured":"Pang Y, Liu X, Wang X, Shi X, Ma L, Zhang Y et al (2022) Edaravone modulates neuronal GPX4\/ACSL4\/5-LOX to promote recovery after spinal cord injury. Front Cell Dev Biology 10:849854","journal-title":"Front Cell Dev Biology"},{"issue":"11","key":"3150_CR24","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/WNR.0000000000000804","volume":"28","author":"N Bergsland","year":"2017","unstructured":"Bergsland N, Agostini S, Lagan\u00e0 MM, Mancuso R, Mendozzi L, Tavazzi E et al (2017) Serum iron concentration is associated with subcortical deep gray matter iron levels in multiple sclerosis patients. NeuroReport 28(11):645\u2013648","journal-title":"NeuroReport"},{"issue":"1\u20133","key":"3150_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1089\/ars.2021.0218","volume":"37","author":"S David","year":"2022","unstructured":"David S, Jhelum P, Ryan F, Jeong SY, Kroner A (2022) Dysregulation of iron homeostasis in the central nervous system and the role of ferroptosis in neurodegenerative disorders. Antioxid Redox Signal 37(1\u20133):150\u2013170","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"3150_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302","journal-title":"Ann Neurol"},{"key":"3150_CR27","doi-asserted-by":"crossref","unstructured":"RAHIMI NAIINI M, Saeidi K, Azarian A, Bahramzadeh K, Nazari-Robati M (2024) Expression analysis of vitamin D receptor-associated long noncoding RNAs in patients with relapsing-remitting multiple sclerosis. Bratislava Med Journal\/Bratislavsk\u00e9 Lek\u00e1rske Listy 125(2):107-112.","DOI":"10.4149\/BLL_2024_018"},{"issue":"2","key":"3150_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/0003-2697(66)90167-9","volume":"16","author":"ZA Placer","year":"1966","unstructured":"Placer ZA, Cushman LL, Johnson BC (1966) Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. Anal Biochem 16(2):359\u2013364","journal-title":"Anal Biochem"},{"issue":"10","key":"3150_CR29","doi-asserted-by":"publisher","first-page":"e13931","DOI":"10.1111\/jfbc.13931","volume":"45","author":"F Bahri","year":"2021","unstructured":"Bahri F, Khaksari M, Movahedinia S, Shafiei B, Rajizadeh MA, Nazari-Robati M (2021) Improving SIRT1 by trehalose supplementation reduces oxidative stress, inflammation, and histopathological scores in the kidney of aged rats. J Food Biochem 45(10):e13931","journal-title":"J Food Biochem"},{"issue":"20","key":"3150_CR30","doi-asserted-by":"publisher","first-page":"11024","DOI":"10.3390\/ijms252011024","volume":"25","author":"L Stojkovic","year":"2024","unstructured":"Stojkovic L, Djordjevic A, Stefanovic M, Stankovic A, Dincic E, Djuric T et al (2024) Circulatory Indicators of Lipid Peroxidation, the Driver of Ferroptosis, Reflect Differences between Relapsing\u2013Remitting and Progressive Multiple Sclerosis. Int J Mol Sci 25(20):11024","journal-title":"Int J Mol Sci"},{"key":"3150_CR31","doi-asserted-by":"publisher","first-page":"137418","DOI":"10.1016\/j.neulet.2023.137418","volume":"813","author":"B Shafiei","year":"2023","unstructured":"Shafiei B, Afgar A, Nematollahi MH, Shabani M, Nazari-Robati M (2023) Effect of trehalose on miR-132 and SIRT1 in the hippocampus of aged rats. Neurosci Lett 813:137418","journal-title":"Neurosci Lett"},{"key":"3150_CR32","doi-asserted-by":"publisher","first-page":"149167","DOI":"10.1016\/j.bbrc.2023.149167","volume":"687","author":"NT Moldogazieva","year":"2023","unstructured":"Moldogazieva NT, Zavadskiy SP, Astakhov DV, Terentiev AA (2023) Lipid peroxidation: Reactive carbonyl species, protein\/DNA adducts, and signaling switches in oxidative stress and cancer. Biochem Biophys Res Commun 687:149167","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3150_CR33","first-page":"360438","volume":"2014","author":"A Ayala","year":"2014","unstructured":"Ayala A, Mu\u00f1oz MF, Arg\u00fcelles S (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy\u20102\u2010nonenal. Oxidative Med Cell Longev 2014(1):360438","journal-title":"Oxidative Med Cell Longev"},{"issue":"6","key":"3150_CR34","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3390\/diagnostics12061365","volume":"12","author":"A Burgetova","year":"2022","unstructured":"Burgetova A, Dusek P, Uher T, Vaneckova M, Vejrazka M, Burgetova R et al (2022) Oxidative stress markers in cerebrospinal fluid of newly diagnosed multiple sclerosis patients and their link to iron deposition and atrophy. Diagnostics 12(6):1365","journal-title":"Diagnostics"},{"issue":"3","key":"3150_CR35","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s12011-014-9956-0","volume":"158","author":"B Yousefi","year":"2014","unstructured":"Yousefi B, Ahmadi Y, Ghorbanihaghjo A, Faghfoori Z, Irannejad VS (2014) Serum arsenic and lipid peroxidation levels in patients with multiple sclerosis. Biol Trace Elem Res 158(3):276\u2013279","journal-title":"Biol Trace Elem Res"},{"issue":"4","key":"3150_CR36","first-page":"543","volume":"65","author":"M Adamczyk-Sowa","year":"2014","unstructured":"Adamczyk-Sowa M, Pierzchala K, Sowa P, Polaniak R, Kukla M, Hartel M (2014) Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients. J Physiol Pharmacol 65(4):543\u2013550","journal-title":"J Physiol Pharmacol"},{"key":"3150_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.msard.2017.11.010","volume":"19","author":"KB Juybari","year":"2018","unstructured":"Juybari KB, Ebrahimi G, Moghaddam MAM, Asadikaram G, Torkzadeh-Mahani M, Akbari M et al (2018) Evaluation of serum arsenic and its effects on antioxidant alterations in relapsing-remitting multiple sclerosis patients. Multiple Scler Relat disorders 19:79\u201384","journal-title":"Multiple Scler Relat disorders"},{"issue":"6","key":"3150_CR38","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1007\/s10072-020-04807-6","volume":"42","author":"M Talebi","year":"2021","unstructured":"Talebi M, Majdi A, Nasiri E, Naseri A, Sadigh-Eteghad S (2021) The correlation between circulating inflammatory, oxidative stress, and neurotrophic factors level with the cognitive outcomes in multiple sclerosis patients. Neurol Sci 42(6):2291\u20132300","journal-title":"Neurol Sci"},{"issue":"1\u20132","key":"3150_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jns.2013.11.006","volume":"337","author":"S Ljubisavljevic","year":"2014","unstructured":"Ljubisavljevic S, Stojanovic I, Cvetkovic T, Vojinovic S, Stojanov D, Stojanovic D et al (2014) Erythrocytes\u2019 antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation. J Neurol Sci 337(1\u20132):8\u201313","journal-title":"J Neurol Sci"},{"key":"3150_CR40","doi-asserted-by":"publisher","first-page":"103432","DOI":"10.1016\/j.msard.2021.103432","volume":"57","author":"A Naseri","year":"2022","unstructured":"Naseri A, Forghani N, Sadigh-Eteghad S, Shanehbandi D, Asadi M, Nasiri E et al (2022) Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients. Multiple Scler Relat Disorders 57:103432","journal-title":"Multiple Scler Relat Disorders"},{"issue":"4","key":"3150_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3109\/00207451003695690","volume":"120","author":"M Ghabaee","year":"2010","unstructured":"Ghabaee M, Jabedari B, Al-E-Eshagh N, Ghaffarpour M, Asadi F (2010) Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain\u2013Barre syndrome and multiple sclerosis patients. Int J Neurosci 120(4):301\u2013304","journal-title":"Int J Neurosci"},{"issue":"7","key":"3150_CR42","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s11011-021-00786-5","volume":"36","author":"V Borisovs","year":"2021","unstructured":"Borisovs V, Bodrenko J, Kalnina J, Sjakste N (2021) Nitrosative stress parameters and the level of oxidized DNA bases in patients with multiple sclerosis. Metab Brain Dis 36(7):1935\u20131941","journal-title":"Metab Brain Dis"},{"issue":"2","key":"3150_CR43","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s12035-019-01774-8","volume":"57","author":"A Perianes-Cachero","year":"2020","unstructured":"Perianes-Cachero A, Lobo MV, Hern\u00e1ndez-Pinto AM, Busto R, Lasunci\u00f3n-Ripa MA, Arilla-Ferreiro E et al (2020) Oxidative stress and lymphocyte alterations in chronic relapsing experimental allergic encephalomyelitis in the rat hippocampus and protective effects of an ethanolamine phosphate salt. Mol Neurobiol 57(2):860\u2013878","journal-title":"Mol Neurobiol"},{"key":"3150_CR44","doi-asserted-by":"publisher","first-page":"649485","DOI":"10.3389\/fnins.2021.649485","volume":"15","author":"S Trifunovic","year":"2021","unstructured":"Trifunovic S, Stevanovic I, Milosevic A, Ristic N, Janjic M, Bjelobaba I et al (2021) The function of the hypothalamic\u2013Pituitary\u2013Adrenal axis during experimental autoimmune encephalomyelitis: Involvement of oxidative stress mediators. Front NeuroSci 15:649485","journal-title":"Front NeuroSci"},{"issue":"1","key":"3150_CR45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s40478-023-01617-7","volume":"11","author":"P Jhelum","year":"2023","unstructured":"Jhelum P, Zandee S, Ryan F, Zarruk JG, Michalke B, Venkataramani V et al (2023) Ferroptosis induces detrimental effects in chronic EAE and its implications for progressive MS. Acta Neuropathol Commun 11(1):121","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"3150_CR46","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/jnc.14604","volume":"148","author":"CL Hu","year":"2019","unstructured":"Hu CL, Nydes M, Shanley KL, Morales Pantoja IE, Howard TA, Bizzozero OA (2019) Reduced expression of the ferroptosis inhibitor glutathione peroxidase-4 in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurochem 148(3):426\u2013439","journal-title":"J Neurochem"},{"key":"3150_CR47","doi-asserted-by":"crossref","unstructured":"Li F, Zong W, Xin C, Ren F, Li N, Li H et al (2024) Unlocking the link: how hippocampal glutathione\u2013glutamate coupling predicts cognitive impairment in multiple sclerosis patients. Cereb Cortex 34(1) :bhad400.","DOI":"10.1093\/cercor\/bhad400"},{"issue":"3","key":"3150_CR48","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/jon.12836","volume":"31","author":"J Arm","year":"2021","unstructured":"Arm J, Al-iedani O, Ribbons K, Lea R, Lechner\u2010Scott J, Ramadan S (2021) Biochemical correlations with fatigue in multiple sclerosis detected by MR 2D localized correlated spectroscopy. J Neuroimaging 31(3):508\u2013516","journal-title":"J Neuroimaging"},{"issue":"3","key":"3150_CR49","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/jcm9030863","volume":"9","author":"F Murgia","year":"2020","unstructured":"Murgia F, Lorefice L, Poddighe S, Fenu G, Secci MA, Marrosu MG et al (2020) Multi-platform characterization of cerebrospinal fluid and serum metabolome of patients affected by relapsing\u2013Remitting and primary progressive multiple sclerosis. J Clin Med 9(3):863","journal-title":"J Clin Med"},{"issue":"8","key":"3150_CR50","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1177\/1352458517711568","volume":"24","author":"I-Y Choi","year":"2018","unstructured":"Choi I-Y, Lee P, Adany P, Hughes AJ, Belliston S, Denney DR et al (2018) In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis. Multiple Scler J 24(8):1029\u20131038","journal-title":"Multiple Scler J"},{"issue":"7","key":"3150_CR51","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1177\/1352458516669441","volume":"23","author":"I-Y Choi","year":"2017","unstructured":"Choi I-Y, Lee P, Hughes AJ, Denney DR, Lynch SG (2017) Longitudinal changes of cerebral glutathione (GSH) levels associated with the clinical course of disease progression in patients with secondary progressive multiple sclerosis. Multiple Scler J 23(7):956\u2013962","journal-title":"Multiple Scler J"},{"issue":"2","key":"3150_CR52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G (2021) Ferroptosis: molecular mechanisms and health implications. Cell Res 31(2):107\u2013125","journal-title":"Cell Res"},{"key":"3150_CR53","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jns.2016.12.039","volume":"373","author":"KPZ Ferreira","year":"2017","unstructured":"Ferreira KPZ, Oliveira SR, Kallaur AP, Kaimen-Maciel DR, Lozovoy MAB, de Almeida ERD et al (2017) Disease progression and oxidative stress are associated with higher serum ferritin levels in patients with multiple sclerosis. J Neurol Sci 373:236\u2013241","journal-title":"J Neurol Sci"},{"issue":"3","key":"3150_CR54","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1191\/1352458505ms1171oa","volume":"11","author":"C Sfagos","year":"2005","unstructured":"Sfagos C, Makis AC, Chaidos A, Hatzimichael EC, Dalamaga A, Kosma K et al (2005) Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients. Multiple Scler J 11(3):272\u2013275","journal-title":"Multiple Scler J"},{"issue":"6","key":"3150_CR55","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1212\/WNL.0b013e31820af7de","volume":"76","author":"G Ristori","year":"2011","unstructured":"Ristori G, Brescianini S, Pino A, Visconti A, Vittori D, Coarelli G et al (2011) Serum elements and oxidative status in clinically isolated syndromes: imbalance and predictivity. Neurology 76(6):549\u2013555","journal-title":"Neurology"},{"key":"3150_CR56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtemb.2019.05.011","volume":"55","author":"HO Do\u011fan","year":"2019","unstructured":"Do\u011fan HO, Yildiz \u00d6K (2019) Serum NADPH oxidase concentrations and the associations with iron metabolism in relapsing remitting multiple sclerosis. J Trace Elem Med Biol 55:39\u201343","journal-title":"J Trace Elem Med Biol"},{"issue":"1","key":"3150_CR57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12035-015-9648-6","volume":"54","author":"AP Kallaur","year":"2017","unstructured":"Kallaur AP, Reiche EMV, Oliveira SR, Sim\u00e3o ANC, Pereira WLCJ, Alfieri DF et al (2017) Genetic, immune-inflammatory, and oxidative stress biomarkers as predictors for disability and disease progression in multiple sclerosis. Mol Neurobiol 54(1):31\u201344","journal-title":"Mol Neurobiol"},{"key":"3150_CR58","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.clinimag.2020.09.006","volume":"69","author":"A Al-Radaideh","year":"2021","unstructured":"Al-Radaideh A, El-Haj N, Hijjawi N (2021) Iron deposition and atrophy in cerebral grey matter and their possible association with serum iron in relapsing-remitting multiple sclerosis. Clin Imaging 69:238\u2013242","journal-title":"Clin Imaging"},{"key":"3150_CR59","doi-asserted-by":"publisher","first-page":"103672","DOI":"10.1016\/j.msard.2022.103672","volume":"60","author":"B Toczylowska","year":"2022","unstructured":"Toczylowska B, Zieminska E, Podlecka-Pietowska A, Ruszczynska A, Chalimoniuk M (2022) Serum metabolic profiles and metal levels of patients with multiple sclerosis and patients with neuromyelitis optica spectrum disorders-NMR spectroscopy and ICP\u2013MS studies. Multiple Scler Relat Disorders 60:103672","journal-title":"Multiple Scler Relat Disorders"},{"issue":"4","key":"3150_CR60","doi-asserted-by":"publisher","first-page":"103741","DOI":"10.1016\/j.autrev.2025.103741","volume":"24","author":"G Bj\u00f8rklund","year":"2025","unstructured":"Bj\u00f8rklund G, Wallace DR, Hangan T, Butnariu M, Gurgas L, Peana M (2025) Cerebral iron accumulation in multiple sclerosis: pathophysiology and therapeutic implications. Autoimmun rev 24(4):103741","journal-title":"Autoimmun rev"},{"issue":"3","key":"3150_CR61","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1021\/acs.jproteome.2c00460","volume":"22","author":"PK Pomary","year":"2023","unstructured":"Pomary PK, Eichau S, Amig\u00f3 N, Barrios L, Matesanz F, Garcia-Valdecasas M et al (2023) Multifaceted analysis of cerebrospinal fluid and serum from progressive multiple sclerosis patients: potential role of vitamin C and metal ion imbalance in the divergence of primary progressive multiple sclerosis and secondary progressive multiple sclerosis. J Proteome Res 22(3):743\u2013757","journal-title":"J Proteome Res"},{"key":"3150_CR62","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fnins.2019.00086","volume":"13","author":"M Siotto","year":"2019","unstructured":"Siotto M, Filippi MM, Simonelli I, Landi D, Ghazaryan A, Vollaro S et al (2019) Oxidative stress related to iron metabolism in relapsing remitting multiple sclerosis patients with low disability. Front NeuroSci 13:86","journal-title":"Front NeuroSci"},{"issue":"5","key":"3150_CR63","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1177\/1352458507085550","volume":"14","author":"N Abo-Krysha","year":"2008","unstructured":"Abo-Krysha N, Rashed L (2008) The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study. Multiple Scler J 14(5):602\u2013608","journal-title":"Multiple Scler J"},{"issue":"2","key":"3150_CR64","first-page":"217","volume":"41","author":"A Visconti","year":"2005","unstructured":"Visconti A, Cotichini R, Cannoni S, Bocca B, Forte G, Ghazaryan A et al (2005) Concentration of elements in serum of patients affected by multiple sclerosis with first demyelinating episode: a six-month longitudinal follow-up study. Annali dell\u2019Istituto superiore di sanita 41(2):217\u2013222","journal-title":"Annali dell\u2019Istituto superiore di sanita"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03150-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-026-03150-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03150-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:30:45Z","timestamp":1793161845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-026-03150-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3150"],"URL":"https:\/\/doi.org\/10.1007\/s13760-026-03150-5","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case-control study was approved by the local ethics committee (IR.KMU.REC.1403.610) and conducted according to the principles of the Helsinki Declaration. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}